nodes	percent_of_prediction	percent_of_DWPC	metapath
Methsuximide—Photophobia—Floxuridine—stomach cancer	0.0247	0.0368	CcSEcCtD
Methsuximide—Pancytopenia—Floxuridine—stomach cancer	0.0157	0.0234	CcSEcCtD
Methsuximide—Gastrointestinal symptom NOS—Fluorouracil—stomach cancer	0.0146	0.0218	CcSEcCtD
Methsuximide—Pancytopenia—Mitomycin—stomach cancer	0.0123	0.0183	CcSEcCtD
Methsuximide—Drowsiness—Mitomycin—stomach cancer	0.0115	0.0172	CcSEcCtD
Methsuximide—Leukopenia—Floxuridine—stomach cancer	0.0103	0.0153	CcSEcCtD
Methsuximide—Confusional state—Floxuridine—stomach cancer	0.00945	0.0141	CcSEcCtD
Methsuximide—Hiccups—Irinotecan—stomach cancer	0.00895	0.0134	CcSEcCtD
Methsuximide—Anorexia—Floxuridine—stomach cancer	0.00893	0.0133	CcSEcCtD
Methsuximide—Vision blurred—Mitomycin—stomach cancer	0.00849	0.0127	CcSEcCtD
Methsuximide—Decreased appetite—Floxuridine—stomach cancer	0.00815	0.0122	CcSEcCtD
Methsuximide—Leukopenia—Mitomycin—stomach cancer	0.00807	0.012	CcSEcCtD
Methsuximide—Photophobia—Fluorouracil—stomach cancer	0.00805	0.012	CcSEcCtD
Methsuximide—Feeling abnormal—Floxuridine—stomach cancer	0.00772	0.0115	CcSEcCtD
Methsuximide—Gastrointestinal pain—Floxuridine—stomach cancer	0.00766	0.0114	CcSEcCtD
Methsuximide—Confusional state—Mitomycin—stomach cancer	0.00742	0.0111	CcSEcCtD
Methsuximide—Abdominal pain—Floxuridine—stomach cancer	0.00741	0.0111	CcSEcCtD
Methsuximide—Anorexia—Mitomycin—stomach cancer	0.00701	0.0105	CcSEcCtD
Methsuximide—Proteinuria—Capecitabine—stomach cancer	0.00682	0.0102	CcSEcCtD
Methsuximide—Protein urine present—Capecitabine—stomach cancer	0.00673	0.01	CcSEcCtD
Methsuximide—Somnolence—Mitomycin—stomach cancer	0.00654	0.00976	CcSEcCtD
Methsuximide—Diarrhoea—Floxuridine—stomach cancer	0.00641	0.00958	CcSEcCtD
Methsuximide—Decreased appetite—Mitomycin—stomach cancer	0.00639	0.00955	CcSEcCtD
Methsuximide—Feeling abnormal—Mitomycin—stomach cancer	0.00606	0.00905	CcSEcCtD
Methsuximide—Hiccups—Capecitabine—stomach cancer	0.00599	0.00895	CcSEcCtD
Methsuximide—Vomiting—Floxuridine—stomach cancer	0.00596	0.0089	CcSEcCtD
Methsuximide—Irritability—Fluorouracil—stomach cancer	0.00594	0.00887	CcSEcCtD
Methsuximide—Rash—Floxuridine—stomach cancer	0.00591	0.00882	CcSEcCtD
Methsuximide—Dermatitis—Floxuridine—stomach cancer	0.0059	0.00882	CcSEcCtD
Methsuximide—Headache—Floxuridine—stomach cancer	0.00587	0.00877	CcSEcCtD
Methsuximide—Ataxia—Fluorouracil—stomach cancer	0.00585	0.00874	CcSEcCtD
Methsuximide—Nausea—Floxuridine—stomach cancer	0.00557	0.00831	CcSEcCtD
Methsuximide—Eosinophilia—Fluorouracil—stomach cancer	0.00533	0.00795	CcSEcCtD
Methsuximide—Pancytopenia—Fluorouracil—stomach cancer	0.00511	0.00763	CcSEcCtD
Methsuximide—Weight decreased—Irinotecan—stomach cancer	0.00508	0.00759	CcSEcCtD
Methsuximide—Proteinuria—Methotrexate—stomach cancer	0.00508	0.00758	CcSEcCtD
Methsuximide—Diarrhoea—Mitomycin—stomach cancer	0.00503	0.00751	CcSEcCtD
Methsuximide—Antipyrine—CYP2A6—stomach cancer	0.00502	0.37	CrCbGaD
Methsuximide—Protein urine present—Methotrexate—stomach cancer	0.00501	0.00748	CcSEcCtD
Methsuximide—Dizziness—Mitomycin—stomach cancer	0.00486	0.00726	CcSEcCtD
Methsuximide—Vomiting—Mitomycin—stomach cancer	0.00468	0.00698	CcSEcCtD
Methsuximide—Rash—Mitomycin—stomach cancer	0.00464	0.00692	CcSEcCtD
Methsuximide—Dermatitis—Mitomycin—stomach cancer	0.00463	0.00692	CcSEcCtD
Methsuximide—Headache—Mitomycin—stomach cancer	0.00461	0.00688	CcSEcCtD
Methsuximide—Nausea—Mitomycin—stomach cancer	0.00437	0.00652	CcSEcCtD
Methsuximide—Ataxia—Docetaxel—stomach cancer	0.00422	0.00631	CcSEcCtD
Methsuximide—Hiccups—Epirubicin—stomach cancer	0.00417	0.00623	CcSEcCtD
Methsuximide—Irritability—Capecitabine—stomach cancer	0.00415	0.0062	CcSEcCtD
Methsuximide—Ataxia—Capecitabine—stomach cancer	0.00409	0.00611	CcSEcCtD
Methsuximide—Hiccups—Doxorubicin—stomach cancer	0.00386	0.00577	CcSEcCtD
Methsuximide—Pancytopenia—Docetaxel—stomach cancer	0.00369	0.00551	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—FYN—stomach cancer	0.00363	0.0115	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CTNNA2—stomach cancer	0.00359	0.0113	CbGpPWpGaD
Methsuximide—Pancytopenia—Capecitabine—stomach cancer	0.00357	0.00533	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—ITGA5—stomach cancer	0.00356	0.0113	CbGpPWpGaD
Methsuximide—Vision blurred—Fluorouracil—stomach cancer	0.00353	0.00527	CcSEcCtD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—FYN—stomach cancer	0.00352	0.0111	CbGpPWpGaD
Methsuximide—Weight decreased—Docetaxel—stomach cancer	0.00351	0.00524	CcSEcCtD
Methsuximide—Leukopenia—Irinotecan—stomach cancer	0.0035	0.00523	CcSEcCtD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—IL6R—stomach cancer	0.00347	0.011	CbGpPWpGaD
Methsuximide—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.00343	0.00512	CcSEcCtD
Methsuximide—Weight decreased—Capecitabine—stomach cancer	0.0034	0.00508	CcSEcCtD
Methsuximide—Leukopenia—Fluorouracil—stomach cancer	0.00336	0.00501	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.00332	0.00496	CcSEcCtD
Methsuximide—Confusional state—Irinotecan—stomach cancer	0.00322	0.00481	CcSEcCtD
Methsuximide—Haematuria—Capecitabine—stomach cancer	0.0032	0.00477	CcSEcCtD
Methsuximide—Irritability—Methotrexate—stomach cancer	0.00309	0.00461	CcSEcCtD
Methsuximide—Confusional state—Fluorouracil—stomach cancer	0.00308	0.00461	CcSEcCtD
Methsuximide—CYP2C19—Xenobiotics—CYP2A6—stomach cancer	0.00308	0.00972	CbGpPWpGaD
Methsuximide—Anorexia—Irinotecan—stomach cancer	0.00304	0.00455	CcSEcCtD
Methsuximide—Ataxia—Methotrexate—stomach cancer	0.00304	0.00455	CcSEcCtD
Methsuximide—CYP2C19—Tamoxifen metabolism—CYP2A6—stomach cancer	0.00296	0.00935	CbGpPWpGaD
Methsuximide—Erythema multiforme—Docetaxel—stomach cancer	0.00294	0.00439	CcSEcCtD
Methsuximide—Anorexia—Fluorouracil—stomach cancer	0.00292	0.00435	CcSEcCtD
Methsuximide—Insomnia—Irinotecan—stomach cancer	0.00289	0.00431	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—IL6ST—stomach cancer	0.00287	0.00906	CbGpPWpGaD
Methsuximide—Ataxia—Epirubicin—stomach cancer	0.00285	0.00425	CcSEcCtD
Methsuximide—Erythema multiforme—Capecitabine—stomach cancer	0.00285	0.00425	CcSEcCtD
Methsuximide—Somnolence—Irinotecan—stomach cancer	0.00284	0.00424	CcSEcCtD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—IL6ST—stomach cancer	0.00278	0.00878	CbGpPWpGaD
Methsuximide—Decreased appetite—Irinotecan—stomach cancer	0.00278	0.00415	CcSEcCtD
Methsuximide—Eosinophilia—Methotrexate—stomach cancer	0.00277	0.00414	CcSEcCtD
Methsuximide—Insomnia—Fluorouracil—stomach cancer	0.00277	0.00413	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Irinotecan—stomach cancer	0.00276	0.00412	CcSEcCtD
Methsuximide—Constipation—Irinotecan—stomach cancer	0.00273	0.00408	CcSEcCtD
Methsuximide—Somnolence—Fluorouracil—stomach cancer	0.00272	0.00406	CcSEcCtD
Methsuximide—Decreased appetite—Fluorouracil—stomach cancer	0.00266	0.00397	CcSEcCtD
Methsuximide—Pancytopenia—Methotrexate—stomach cancer	0.00266	0.00397	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.00264	0.00394	CcSEcCtD
Methsuximide—Ataxia—Doxorubicin—stomach cancer	0.00264	0.00394	CcSEcCtD
Methsuximide—Feeling abnormal—Irinotecan—stomach cancer	0.00263	0.00393	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—ITGA5—stomach cancer	0.00263	0.00829	CbGpPWpGaD
Methsuximide—Gastrointestinal pain—Irinotecan—stomach cancer	0.00261	0.0039	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—PRNP—stomach cancer	0.00261	0.00823	CbGpPWpGaD
Methsuximide—Eosinophilia—Epirubicin—stomach cancer	0.00259	0.00387	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—IL6R—stomach cancer	0.00256	0.00809	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ITGA5—stomach cancer	0.00254	0.00803	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ITGA5—stomach cancer	0.00254	0.00803	CbGpPWpGaD
Methsuximide—Abdominal pain—Irinotecan—stomach cancer	0.00253	0.00377	CcSEcCtD
Methsuximide—Feeling abnormal—Fluorouracil—stomach cancer	0.00252	0.00376	CcSEcCtD
Methsuximide—Drowsiness—Methotrexate—stomach cancer	0.0025	0.00373	CcSEcCtD
Methsuximide—Pancytopenia—Epirubicin—stomach cancer	0.00249	0.00371	CcSEcCtD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—IL6R—stomach cancer	0.00248	0.00783	CbGpPWpGaD
Methsuximide—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.00247	0.00369	CcSEcCtD
Methsuximide—Vision blurred—Capecitabine—stomach cancer	0.00247	0.00369	CcSEcCtD
Methsuximide—Phenobarbital—CYP2A6—stomach cancer	0.00245	0.181	CrCbGaD
Methsuximide—Urticaria—Fluorouracil—stomach cancer	0.00243	0.00363	CcSEcCtD
Methsuximide—Leukopenia—Docetaxel—stomach cancer	0.00242	0.00362	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—APC—stomach cancer	0.00242	0.00765	CbGpPWpGaD
Methsuximide—Eosinophilia—Doxorubicin—stomach cancer	0.0024	0.00358	CcSEcCtD
Methsuximide—Haematuria—Methotrexate—stomach cancer	0.00238	0.00355	CcSEcCtD
Methsuximide—Weight decreased—Epirubicin—stomach cancer	0.00237	0.00354	CcSEcCtD
Methsuximide—Leukopenia—Capecitabine—stomach cancer	0.00234	0.0035	CcSEcCtD
Methsuximide—Drowsiness—Epirubicin—stomach cancer	0.00234	0.00349	CcSEcCtD
Methsuximide—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.00232	0.00346	CcSEcCtD
Methsuximide—Pancytopenia—Doxorubicin—stomach cancer	0.0023	0.00344	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—stomach cancer	0.00223	0.00704	CbGpPWpGaD
Methsuximide—Haematuria—Epirubicin—stomach cancer	0.00223	0.00332	CcSEcCtD
Methsuximide—Confusional state—Docetaxel—stomach cancer	0.00223	0.00332	CcSEcCtD
Methsuximide—Antipyrine—PTGS2—stomach cancer	0.0022	0.162	CrCbGaD
Methsuximide—Weight decreased—Doxorubicin—stomach cancer	0.00219	0.00327	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—PRKCB—stomach cancer	0.00219	0.00692	CbGpPWpGaD
Methsuximide—Diarrhoea—Irinotecan—stomach cancer	0.00219	0.00326	CcSEcCtD
Methsuximide—CACNA1I—Developmental Biology—SREBF2—stomach cancer	0.00216	0.00683	CbGpPWpGaD
Methsuximide—Drowsiness—Doxorubicin—stomach cancer	0.00216	0.00323	CcSEcCtD
Methsuximide—Confusional state—Capecitabine—stomach cancer	0.00216	0.00322	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—stomach cancer	0.00215	0.00678	CbGpPWpGaD
Methsuximide—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.00214	0.0032	CcSEcCtD
Methsuximide—Erythema multiforme—Methotrexate—stomach cancer	0.00212	0.00316	CcSEcCtD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—MAPK3—stomach cancer	0.00212	0.00668	CbGpPWpGaD
Methsuximide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	0.00211	0.00667	CbGpPWpGaD
Methsuximide—Dizziness—Irinotecan—stomach cancer	0.00211	0.00315	CcSEcCtD
Methsuximide—Anorexia—Docetaxel—stomach cancer	0.0021	0.00314	CcSEcCtD
Methsuximide—Diarrhoea—Fluorouracil—stomach cancer	0.00209	0.00313	CcSEcCtD
Methsuximide—Haematuria—Doxorubicin—stomach cancer	0.00206	0.00308	CcSEcCtD
Methsuximide—CYP2C19—Melatonin metabolism and effects—ADRB1—stomach cancer	0.00206	0.0065	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—HSPA8—stomach cancer	0.00206	0.00649	CbGpPWpGaD
Methsuximide—Anorexia—Capecitabine—stomach cancer	0.00204	0.00304	CcSEcCtD
Methsuximide—Vomiting—Irinotecan—stomach cancer	0.00203	0.00303	CcSEcCtD
Methsuximide—Dizziness—Fluorouracil—stomach cancer	0.00202	0.00302	CcSEcCtD
Methsuximide—Rash—Irinotecan—stomach cancer	0.00201	0.00301	CcSEcCtD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—MAPK1—stomach cancer	0.00201	0.00636	CbGpPWpGaD
Methsuximide—Dermatitis—Irinotecan—stomach cancer	0.00201	0.003	CcSEcCtD
Methsuximide—Headache—Irinotecan—stomach cancer	0.002	0.00299	CcSEcCtD
Methsuximide—Insomnia—Docetaxel—stomach cancer	0.002	0.00298	CcSEcCtD
Methsuximide—Erythema multiforme—Epirubicin—stomach cancer	0.00198	0.00296	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—stomach cancer	0.00197	0.00621	CbGpPWpGaD
Methsuximide—Somnolence—Docetaxel—stomach cancer	0.00196	0.00293	CcSEcCtD
Methsuximide—Vomiting—Fluorouracil—stomach cancer	0.00195	0.0029	CcSEcCtD
Methsuximide—Insomnia—Capecitabine—stomach cancer	0.00193	0.00289	CcSEcCtD
Methsuximide—Rash—Fluorouracil—stomach cancer	0.00193	0.00288	CcSEcCtD
Methsuximide—Dermatitis—Fluorouracil—stomach cancer	0.00193	0.00288	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—PRNP—stomach cancer	0.00192	0.00607	CbGpPWpGaD
Methsuximide—Decreased appetite—Docetaxel—stomach cancer	0.00192	0.00287	CcSEcCtD
Methsuximide—Headache—Fluorouracil—stomach cancer	0.00192	0.00286	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00191	0.00285	CcSEcCtD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—KRAS—stomach cancer	0.0019	0.00601	CbGpPWpGaD
Methsuximide—Nausea—Irinotecan—stomach cancer	0.0019	0.00283	CcSEcCtD
Methsuximide—Constipation—Docetaxel—stomach cancer	0.00189	0.00282	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—ITGA5—stomach cancer	0.00187	0.00592	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—PRNP—stomach cancer	0.00186	0.00588	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PRNP—stomach cancer	0.00186	0.00588	CbGpPWpGaD
Methsuximide—Decreased appetite—Capecitabine—stomach cancer	0.00186	0.00277	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00185	0.00276	CcSEcCtD
Methsuximide—Vision blurred—Methotrexate—stomach cancer	0.00184	0.00274	CcSEcCtD
Methsuximide—Erythema multiforme—Doxorubicin—stomach cancer	0.00183	0.00274	CcSEcCtD
Methsuximide—Constipation—Capecitabine—stomach cancer	0.00183	0.00273	CcSEcCtD
Methsuximide—Feeling abnormal—Docetaxel—stomach cancer	0.00182	0.00272	CcSEcCtD
Methsuximide—Nausea—Fluorouracil—stomach cancer	0.00182	0.00271	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—ITGA5—stomach cancer	0.00181	0.00573	CbGpPWpGaD
Methsuximide—Gastrointestinal pain—Docetaxel—stomach cancer	0.00181	0.0027	CcSEcCtD
Methsuximide—Tension—Epirubicin—stomach cancer	0.00179	0.00267	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—stomach cancer	0.00178	0.00563	CbGpPWpGaD
Methsuximide—Nervousness—Epirubicin—stomach cancer	0.00177	0.00265	CcSEcCtD
Methsuximide—Feeling abnormal—Capecitabine—stomach cancer	0.00176	0.00263	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—RHOA—stomach cancer	0.00176	0.00556	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CDH2—stomach cancer	0.00175	0.00552	CbGpPWpGaD
Methsuximide—Gastrointestinal pain—Capecitabine—stomach cancer	0.00175	0.00261	CcSEcCtD
Methsuximide—Abdominal pain—Docetaxel—stomach cancer	0.00175	0.00261	CcSEcCtD
Methsuximide—Leukopenia—Methotrexate—stomach cancer	0.00175	0.00261	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—NOS3—stomach cancer	0.00174	0.0055	CbGpPWpGaD
Methsuximide—Vision blurred—Epirubicin—stomach cancer	0.00172	0.00257	CcSEcCtD
Methsuximide—CYP2C19—Arachidonic acid metabolism—ALOX5—stomach cancer	0.00172	0.00543	CbGpPWpGaD
Methsuximide—Urticaria—Capecitabine—stomach cancer	0.0017	0.00254	CcSEcCtD
Methsuximide—Abdominal pain—Capecitabine—stomach cancer	0.00169	0.00252	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—stomach cancer	0.00166	0.00525	CbGpPWpGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—stomach cancer	0.00166	0.00524	CbGpPWpGaD
Methsuximide—Tension—Doxorubicin—stomach cancer	0.00166	0.00247	CcSEcCtD
Methsuximide—Nervousness—Doxorubicin—stomach cancer	0.00164	0.00245	CcSEcCtD
Methsuximide—Leukopenia—Epirubicin—stomach cancer	0.00163	0.00244	CcSEcCtD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—HRAS—stomach cancer	0.00162	0.00511	CbGpPWpGaD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—stomach cancer	0.00161	0.00509	CbGpPWpGaD
Methsuximide—Confusional state—Methotrexate—stomach cancer	0.0016	0.0024	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—SREBF2—stomach cancer	0.00159	0.00503	CbGpPWpGaD
Methsuximide—Vision blurred—Doxorubicin—stomach cancer	0.00159	0.00238	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—MAPK3—stomach cancer	0.00156	0.00493	CbGpPWpGaD
Methsuximide—CACNA1I—NCAM signaling for neurite out-growth—IL6—stomach cancer	0.00155	0.00489	CbGpPWpGaD
Methsuximide—Ketazolam—ALB—stomach cancer	0.00155	0.114	CrCbGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—CXCL8—stomach cancer	0.00154	0.00488	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SREBF2—stomach cancer	0.00154	0.00487	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PAX6—stomach cancer	0.00154	0.00486	CbGpPWpGaD
Methsuximide—Anorexia—Methotrexate—stomach cancer	0.00152	0.00226	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—HSPA8—stomach cancer	0.00152	0.00479	CbGpPWpGaD
Methsuximide—Leukopenia—Doxorubicin—stomach cancer	0.00151	0.00226	CcSEcCtD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—MAPK3—stomach cancer	0.00151	0.00477	CbGpPWpGaD
Methsuximide—Diarrhoea—Docetaxel—stomach cancer	0.00151	0.00226	CcSEcCtD
Methsuximide—Confusional state—Epirubicin—stomach cancer	0.0015	0.00224	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—MAPK1—stomach cancer	0.00148	0.00469	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—HSPA8—stomach cancer	0.00147	0.00463	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—HSPA8—stomach cancer	0.00147	0.00463	CbGpPWpGaD
Methsuximide—Diarrhoea—Capecitabine—stomach cancer	0.00146	0.00218	CcSEcCtD
Methsuximide—Dizziness—Docetaxel—stomach cancer	0.00146	0.00218	CcSEcCtD
Methsuximide—Insomnia—Methotrexate—stomach cancer	0.00144	0.00215	CcSEcCtD
Methsuximide—CYP2C19—Arachidonic acid metabolism—AKR1C3—stomach cancer	0.00144	0.00454	CbGpPWpGaD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—MAPK1—stomach cancer	0.00144	0.00454	CbGpPWpGaD
Methsuximide—Anorexia—Epirubicin—stomach cancer	0.00142	0.00212	CcSEcCtD
Methsuximide—Somnolence—Methotrexate—stomach cancer	0.00141	0.00211	CcSEcCtD
Methsuximide—Dizziness—Capecitabine—stomach cancer	0.00141	0.00211	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—FYN—stomach cancer	0.00141	0.00446	CbGpPWpGaD
Methsuximide—Vomiting—Docetaxel—stomach cancer	0.0014	0.0021	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—KRAS—stomach cancer	0.0014	0.00443	CbGpPWpGaD
Methsuximide—Rash—Docetaxel—stomach cancer	0.00139	0.00208	CcSEcCtD
Methsuximide—Dermatitis—Docetaxel—stomach cancer	0.00139	0.00208	CcSEcCtD
Methsuximide—Confusional state—Doxorubicin—stomach cancer	0.00139	0.00207	CcSEcCtD
Methsuximide—Decreased appetite—Methotrexate—stomach cancer	0.00138	0.00207	CcSEcCtD
Methsuximide—Headache—Docetaxel—stomach cancer	0.00138	0.00207	CcSEcCtD
Methsuximide—Gastrointestinal disorder—Methotrexate—stomach cancer	0.00137	0.00205	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—PRNP—stomach cancer	0.00137	0.00433	CbGpPWpGaD
Methsuximide—Vomiting—Capecitabine—stomach cancer	0.00136	0.00203	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—MAPK8—stomach cancer	0.00136	0.00429	CbGpPWpGaD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—KRAS—stomach cancer	0.00136	0.00429	CbGpPWpGaD
Methsuximide—Pethidine—ALB—stomach cancer	0.00135	0.0998	CrCbGaD
Methsuximide—Rash—Capecitabine—stomach cancer	0.00135	0.00201	CcSEcCtD
Methsuximide—Insomnia—Epirubicin—stomach cancer	0.00135	0.00201	CcSEcCtD
Methsuximide—Dermatitis—Capecitabine—stomach cancer	0.00135	0.00201	CcSEcCtD
Methsuximide—Headache—Capecitabine—stomach cancer	0.00134	0.002	CcSEcCtD
Methsuximide—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—stomach cancer	0.00133	0.00421	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PRNP—stomach cancer	0.00133	0.0042	CbGpPWpGaD
Methsuximide—Somnolence—Epirubicin—stomach cancer	0.00132	0.00198	CcSEcCtD
Methsuximide—Anorexia—Doxorubicin—stomach cancer	0.00131	0.00196	CcSEcCtD
Methsuximide—Nausea—Docetaxel—stomach cancer	0.00131	0.00196	CcSEcCtD
Methsuximide—Feeling abnormal—Methotrexate—stomach cancer	0.00131	0.00196	CcSEcCtD
Methsuximide—Gastrointestinal pain—Methotrexate—stomach cancer	0.0013	0.00194	CcSEcCtD
Methsuximide—Decreased appetite—Epirubicin—stomach cancer	0.00129	0.00193	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—CDH2—stomach cancer	0.00129	0.00407	CbGpPWpGaD
Methsuximide—Gastrointestinal disorder—Epirubicin—stomach cancer	0.00129	0.00192	CcSEcCtD
Methsuximide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.00128	0.00404	CbGpPWpGaD
Methsuximide—Constipation—Epirubicin—stomach cancer	0.00127	0.0019	CcSEcCtD
Methsuximide—Nausea—Capecitabine—stomach cancer	0.00127	0.0019	CcSEcCtD
Methsuximide—Urticaria—Methotrexate—stomach cancer	0.00126	0.00189	CcSEcCtD
Methsuximide—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.00126	0.00398	CbGpPWpGaD
Methsuximide—Abdominal pain—Methotrexate—stomach cancer	0.00126	0.00188	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—CDH2—stomach cancer	0.00125	0.00394	CbGpPWpGaD
Methsuximide—Insomnia—Doxorubicin—stomach cancer	0.00125	0.00186	CcSEcCtD
Methsuximide—Feeling abnormal—Epirubicin—stomach cancer	0.00123	0.00183	CcSEcCtD
Methsuximide—Somnolence—Doxorubicin—stomach cancer	0.00123	0.00183	CcSEcCtD
Methsuximide—Gastrointestinal pain—Epirubicin—stomach cancer	0.00122	0.00182	CcSEcCtD
Methsuximide—Decreased appetite—Doxorubicin—stomach cancer	0.0012	0.00179	CcSEcCtD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—HRAS—stomach cancer	0.00119	0.00376	CbGpPWpGaD
Methsuximide—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.00119	0.00178	CcSEcCtD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—MAPK3—stomach cancer	0.00119	0.00375	CbGpPWpGaD
Methsuximide—Urticaria—Epirubicin—stomach cancer	0.00118	0.00177	CcSEcCtD
Methsuximide—Constipation—Doxorubicin—stomach cancer	0.00118	0.00176	CcSEcCtD
Methsuximide—Abdominal pain—Epirubicin—stomach cancer	0.00118	0.00176	CcSEcCtD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—HRAS—stomach cancer	0.00115	0.00365	CbGpPWpGaD
Methsuximide—CACNA1G—NCAM signaling for neurite out-growth—IL6—stomach cancer	0.00114	0.0036	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MET—stomach cancer	0.00114	0.0036	CbGpPWpGaD
Methsuximide—Feeling abnormal—Doxorubicin—stomach cancer	0.00114	0.0017	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—PAX6—stomach cancer	0.00114	0.00359	CbGpPWpGaD
Methsuximide—CACNA1H—Corticotropin-releasing hormone—MAPK1—stomach cancer	0.00113	0.00357	CbGpPWpGaD
Methsuximide—Gastrointestinal pain—Doxorubicin—stomach cancer	0.00113	0.00168	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—IL6ST—stomach cancer	0.00112	0.00353	CbGpPWpGaD
Methsuximide—CACNA1H—NCAM signaling for neurite out-growth—IL6—stomach cancer	0.0011	0.00349	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PAX6—stomach cancer	0.0011	0.00347	CbGpPWpGaD
Methsuximide—Urticaria—Doxorubicin—stomach cancer	0.00109	0.00163	CcSEcCtD
Methsuximide—Abdominal pain—Doxorubicin—stomach cancer	0.00109	0.00163	CcSEcCtD
Methsuximide—Diarrhoea—Methotrexate—stomach cancer	0.00109	0.00163	CcSEcCtD
Methsuximide—CACNA1G—Developmental Biology—HSPA8—stomach cancer	0.00108	0.00341	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—SMAD4—stomach cancer	0.00106	0.00335	CbGpPWpGaD
Methsuximide—Dizziness—Methotrexate—stomach cancer	0.00105	0.00157	CcSEcCtD
Methsuximide—CACNA1H—Developmental Biology—HSPA8—stomach cancer	0.00105	0.00331	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—FYN—stomach cancer	0.00104	0.00329	CbGpPWpGaD
Methsuximide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.00104	0.00327	CbGpPWpGaD
Methsuximide—Diarrhoea—Epirubicin—stomach cancer	0.00102	0.00152	CcSEcCtD
Methsuximide—Vomiting—Methotrexate—stomach cancer	0.00101	0.00151	CcSEcCtD
Methsuximide—CACNA1H—Axon guidance—FYN—stomach cancer	0.00101	0.00319	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—FYN—stomach cancer	0.00101	0.00318	CbGpPWpGaD
Methsuximide—Rash—Methotrexate—stomach cancer	0.001	0.0015	CcSEcCtD
Methsuximide—Dermatitis—Methotrexate—stomach cancer	0.001	0.0015	CcSEcCtD
Methsuximide—Headache—Methotrexate—stomach cancer	0.000997	0.00149	CcSEcCtD
Methsuximide—Phenytoin—ALB—stomach cancer	0.000997	0.0735	CrCbGaD
Methsuximide—CACNA1I—Axon guidance—IL6R—stomach cancer	0.000996	0.00315	CbGpPWpGaD
Methsuximide—Dizziness—Epirubicin—stomach cancer	0.000985	0.00147	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—MMP2—stomach cancer	0.000951	0.003	CbGpPWpGaD
Methsuximide—Vomiting—Epirubicin—stomach cancer	0.000947	0.00141	CcSEcCtD
Methsuximide—Nausea—Methotrexate—stomach cancer	0.000945	0.00141	CcSEcCtD
Methsuximide—Diarrhoea—Doxorubicin—stomach cancer	0.000943	0.00141	CcSEcCtD
Methsuximide—Rash—Epirubicin—stomach cancer	0.000939	0.0014	CcSEcCtD
Methsuximide—Dermatitis—Epirubicin—stomach cancer	0.000938	0.0014	CcSEcCtD
Methsuximide—Headache—Epirubicin—stomach cancer	0.000933	0.00139	CcSEcCtD
Methsuximide—Dizziness—Doxorubicin—stomach cancer	0.000911	0.00136	CcSEcCtD
Methsuximide—CACNA1I—Axon guidance—RHOA—stomach cancer	0.0009	0.00284	CbGpPWpGaD
Methsuximide—Nausea—Epirubicin—stomach cancer	0.000885	0.00132	CcSEcCtD
Methsuximide—Vomiting—Doxorubicin—stomach cancer	0.000876	0.00131	CcSEcCtD
Methsuximide—Rash—Doxorubicin—stomach cancer	0.000869	0.0013	CcSEcCtD
Methsuximide—Dermatitis—Doxorubicin—stomach cancer	0.000868	0.0013	CcSEcCtD
Methsuximide—Headache—Doxorubicin—stomach cancer	0.000863	0.00129	CcSEcCtD
Methsuximide—CACNA1G—Axon guidance—MET—stomach cancer	0.00084	0.00265	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—ERBB2—stomach cancer	0.000833	0.00263	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6ST—stomach cancer	0.000823	0.0026	CbGpPWpGaD
Methsuximide—Nausea—Doxorubicin—stomach cancer	0.000819	0.00122	CcSEcCtD
Methsuximide—CACNA1H—Axon guidance—MET—stomach cancer	0.000814	0.00257	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MET—stomach cancer	0.000813	0.00257	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—CDK4—stomach cancer	0.000813	0.00257	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6ST—stomach cancer	0.000797	0.00252	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6ST—stomach cancer	0.000797	0.00252	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—SMAD4—stomach cancer	0.000783	0.00247	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—SMAD4—stomach cancer	0.000758	0.00239	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—FYN—stomach cancer	0.000743	0.00235	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—PPARG—stomach cancer	0.000739	0.00233	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6R—stomach cancer	0.000734	0.00232	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—FYN—stomach cancer	0.00072	0.00227	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MMP9—stomach cancer	0.000714	0.00226	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6R—stomach cancer	0.000711	0.00225	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6R—stomach cancer	0.000711	0.00225	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP2—stomach cancer	0.000701	0.00221	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MMP2—stomach cancer	0.000679	0.00214	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP2—stomach cancer	0.000678	0.00214	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—RHOA—stomach cancer	0.000663	0.0021	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—RHOA—stomach cancer	0.000642	0.00203	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—RHOA—stomach cancer	0.000642	0.00203	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—VEGFA—stomach cancer	0.000642	0.00203	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—ERBB2—stomach cancer	0.000614	0.00194	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MAPK3—stomach cancer	0.000607	0.00192	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—CDK4—stomach cancer	0.0006	0.00189	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MET—stomach cancer	0.0006	0.00189	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—ERBB2—stomach cancer	0.000595	0.00188	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—ERBB2—stomach cancer	0.000594	0.00188	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6ST—stomach cancer	0.000587	0.00186	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MET—stomach cancer	0.000581	0.00183	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—CDK4—stomach cancer	0.000581	0.00183	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—MAPK1—stomach cancer	0.000577	0.00182	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—EGFR—stomach cancer	0.000577	0.00182	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6ST—stomach cancer	0.000569	0.0018	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTT1—stomach cancer	0.000557	0.00176	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—CYP2A6—stomach cancer	0.00055	0.00174	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—KRAS—stomach cancer	0.000545	0.00172	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—PPARG—stomach cancer	0.000545	0.00172	CbGpPWpGaD
Methsuximide—CYP2C19—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000537	0.0017	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—AKR1C3—stomach cancer	0.000528	0.00167	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—PPARG—stomach cancer	0.000528	0.00167	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MMP9—stomach cancer	0.000527	0.00166	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6R—stomach cancer	0.000524	0.00166	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MMP9—stomach cancer	0.00051	0.00161	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MMP9—stomach cancer	0.00051	0.00161	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6R—stomach cancer	0.000508	0.0016	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP2—stomach cancer	0.0005	0.00158	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP2—stomach cancer	0.000484	0.00153	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.00048	0.00152	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—RHOA—stomach cancer	0.000473	0.0015	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—VEGFA—stomach cancer	0.000473	0.00149	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—HRAS—stomach cancer	0.000464	0.00146	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—RHOA—stomach cancer	0.000458	0.00145	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—VEGFA—stomach cancer	0.000458	0.00145	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—VEGFA—stomach cancer	0.000458	0.00145	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—STAT3—stomach cancer	0.000453	0.00143	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MAPK3—stomach cancer	0.000447	0.00141	CbGpPWpGaD
Methsuximide—CACNA1I—Axon guidance—IL6—stomach cancer	0.000444	0.0014	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—ERBB2—stomach cancer	0.000438	0.00138	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MAPK3—stomach cancer	0.000433	0.00137	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MAPK3—stomach cancer	0.000433	0.00137	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—MAPK1—stomach cancer	0.000426	0.00134	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—EGFR—stomach cancer	0.000426	0.00134	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—ERBB2—stomach cancer	0.000424	0.00134	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—MAPK1—stomach cancer	0.000412	0.0013	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—EGFR—stomach cancer	0.000412	0.0013	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—MAPK1—stomach cancer	0.000412	0.0013	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—EGFR—stomach cancer	0.000412	0.0013	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000402	0.00127	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—KRAS—stomach cancer	0.000402	0.00127	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—TNF—stomach cancer	0.000392	0.00124	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—KRAS—stomach cancer	0.000389	0.00123	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—KRAS—stomach cancer	0.000389	0.00123	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTP1—stomach cancer	0.000386	0.00122	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTP1—stomach cancer	0.000381	0.0012	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MMP9—stomach cancer	0.000376	0.00119	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MMP9—stomach cancer	0.000364	0.00115	CbGpPWpGaD
Methsuximide—CYP2C19—Biological oxidations—GSTM1—stomach cancer	0.000355	0.00112	CbGpPWpGaD
Methsuximide—CYP2C19—Metapathway biotransformation—GSTM1—stomach cancer	0.00035	0.0011	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—HRAS—stomach cancer	0.000342	0.00108	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—VEGFA—stomach cancer	0.000338	0.00107	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—STAT3—stomach cancer	0.000334	0.00106	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ACAD8—stomach cancer	0.000332	0.00105	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—HRAS—stomach cancer	0.000331	0.00105	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—HRAS—stomach cancer	0.000331	0.00104	CbGpPWpGaD
Methsuximide—CACNA1G—Axon guidance—IL6—stomach cancer	0.000327	0.00103	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—VEGFA—stomach cancer	0.000327	0.00103	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000324	0.00102	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—STAT3—stomach cancer	0.000324	0.00102	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MAPK3—stomach cancer	0.000319	0.00101	CbGpPWpGaD
Methsuximide—CACNA1H—Axon guidance—IL6—stomach cancer	0.000317	0.001	CbGpPWpGaD
Methsuximide—CACNA1I—Developmental Biology—IL6—stomach cancer	0.000317	0.001	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MAPK3—stomach cancer	0.000309	0.000977	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000305	0.000963	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—MAPK1—stomach cancer	0.000304	0.000959	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—EGFR—stomach cancer	0.000304	0.000959	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GMPR2—stomach cancer	0.000296	0.000934	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—MAPK1—stomach cancer	0.000294	0.000929	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—EGFR—stomach cancer	0.000294	0.000929	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—TNF—stomach cancer	0.000289	0.000914	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—KRAS—stomach cancer	0.000287	0.000906	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000286	0.000902	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000282	0.000891	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—TNF—stomach cancer	0.00028	0.000885	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—KRAS—stomach cancer	0.000278	0.000878	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SUCLG1—stomach cancer	0.00027	0.000854	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—IDH3B—stomach cancer	0.00027	0.000854	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NDUFV1—stomach cancer	0.000251	0.000794	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NDUFS1—stomach cancer	0.000251	0.000794	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000246	0.000776	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—HRAS—stomach cancer	0.000244	0.00077	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—HRAS—stomach cancer	0.000236	0.000746	CbGpPWpGaD
Methsuximide—CACNA1G—Developmental Biology—IL6—stomach cancer	0.000233	0.000737	CbGpPWpGaD
Methsuximide—CACNA1H—Developmental Biology—IL6—stomach cancer	0.000226	0.000714	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PGLS—stomach cancer	0.000224	0.000708	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—BLVRB—stomach cancer	0.000224	0.000708	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPAP2A—stomach cancer	0.000214	0.000675	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000206	0.000649	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CKB—stomach cancer	0.000191	0.000602	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NDUFA2—stomach cancer	0.000191	0.000602	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—FBP1—stomach cancer	0.000191	0.000602	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA1—stomach cancer	0.000191	0.000602	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLIN2—stomach cancer	0.000179	0.000566	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CA2—stomach cancer	0.000174	0.00055	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NT5E—stomach cancer	0.00017	0.000536	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PGAM1—stomach cancer	0.00017	0.000536	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDH7A1—stomach cancer	0.000162	0.000512	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PLCE1—stomach cancer	0.000162	0.000512	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—UMPS—stomach cancer	0.000155	0.000491	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PDHA1—stomach cancer	0.000144	0.000456	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ECHS1—stomach cancer	0.000144	0.000456	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TYMP—stomach cancer	0.000136	0.000429	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—FADS1—stomach cancer	0.000136	0.000429	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—SREBF2—stomach cancer	0.000127	0.000402	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—RORA—stomach cancer	0.000126	0.000397	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALDOB—stomach cancer	0.000118	0.000372	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000111	0.000351	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000111	0.00035	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALOX5—stomach cancer	0.000109	0.000346	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—DPYD—stomach cancer	0.000108	0.00034	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	9.76e-05	0.000308	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTT1—stomach cancer	9.52e-05	0.000301	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CYP2A6—stomach cancer	9.41e-05	0.000297	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—AKR1C3—stomach cancer	9.16e-05	0.000289	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ENO1—stomach cancer	8.92e-05	0.000282	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	8.78e-05	0.000277	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CD44—stomach cancer	7.91e-05	0.00025	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	7.68e-05	0.000242	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPP2R1A—stomach cancer	6.73e-05	0.000213	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTP1—stomach cancer	6.6e-05	0.000208	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—HMOX1—stomach cancer	6.51e-05	0.000206	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—TYMS—stomach cancer	6.14e-05	0.000194	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—GSTM1—stomach cancer	6.07e-05	0.000192	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ERCC2—stomach cancer	5.7e-05	0.00018	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—MTHFR—stomach cancer	5.36e-05	0.000169	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—CAV1—stomach cancer	4.94e-05	0.000156	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—APOA1—stomach cancer	4.93e-05	0.000156	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.72e-05	0.000149	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PPARG—stomach cancer	4.35e-05	0.000137	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—ALB—stomach cancer	3.91e-05	0.000123	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—NOS3—stomach cancer	3.74e-05	0.000118	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PTGS2—stomach cancer	3.42e-05	0.000108	CbGpPWpGaD
Methsuximide—CYP2C19—Metabolism—PIK3CA—stomach cancer	2.1e-05	6.64e-05	CbGpPWpGaD
